Immunotherapy advances Journal

Overview

publication venue for

Combination of genetically engineered T cells and immune checkpoint blockade for the treatment of cancer. 2022

Identity

ISO Abbreviation

Immunother Adv

Linking ISSN

2732-4303

Electronic International Standard Serial Number (EISSN)

2732-4303